衰弱老年患者肋骨骨折:手术稳定是否改善结局
该研究基于创伤质量改进计划数据库6年(2017-2022)回顾性分析,纳入≥65岁、改良衰弱指数≥0.25、孤立性钝性胸部创伤且≥2根肋骨骨折的衰弱患者。共53,630例中2%接受手术稳定,经1:1倾向评分匹配各1,063例后,手术稳定组死亡率5.4% vs 非手术组10.2%(p<0.001),但呼吸机相关性肺炎、急性呼吸窘迫综合征、气管切开无差异,手术组ICU再入率和住院及ICU住院时间更高。亚组分析(n=916)显示晚期(>72小时)手术与更多无计划插管、ICU再入、气管切开及更长住院、ICU和通气时间相关。结论提示手术稳定与衰弱老年多根肋骨骨折患者死亡率降低相关,早期手术(≤72小时)与更少上述并发症相关。
要点
- 衰弱老年(≥65岁,mFI≥0.25)孤立性钝性胸部创伤且≥2根肋骨骨折患者中,手术稳定组死亡率5.4% vs 非手术组10.2%(p<0.001)。
- 手术稳定未降低呼吸机相关性肺炎、急性呼吸窘迫综合征或气管切开发生率,但ICU再入率和住院及ICU住院时间更高(p<0.05)。
- 亚组分析(n=916)中,晚期手术(>72小时)较早期手术(≤72小时)无计划插管10.7% vs 6.8%、ICU再入15.5% vs 7.6%、气管切开7.0% vs 3.5%。
- 晚期手术较早期手术住院时间13天 vs 10天、ICU时间8天 vs 6天、通气时间7天 vs 4天(p<0.001)。
- 作者认为早期(≤72小时)手术稳定与减少无计划插管、ICU再入、气管切开、住院时间和通气需求相关。
适用人群与场景
- 纳入:≥65岁、改良衰弱指数(mFI)≥0.25、孤立性钝性胸部创伤且≥2根肋骨骨折的衰弱老年患者。
诊断标准与关键阈值
- 衰弱定义:11项改良衰弱指数(mFI)≥0.25。
- 早期手术:手术稳定肋骨骨折(SSRF)在≤72小时内实施;晚期手术:>72小时实施。
研究设计与关键结果
- 研究设计:6年(2017-2022)创伤质量改进计划数据库回顾性分析,1:1倾向评分匹配调整人口学、损伤严重度和基线特征。
- 样本:53,630例衰弱肋骨骨折患者中2%接受SSRF;倾向评分匹配后SSRF组与非手术组各1,063例。
- 主要终点:SSRF组死亡率5.4% vs 非手术组10.2%(p<0.001);呼吸机相关性肺炎、急性呼吸窘迫综合征、气管切开无差异。
- 次要终点:SSRF组ICU再入率更高、住院和ICU住院时间更长(p<0.05)。
- 亚组分析(n=916):晚期SSRF vs 早期SSRF,无计划插管10.7% vs 6.8%、ICU再入15.5% vs 7.6%、气管切开7.0% vs 3.5%、住院时间13天 vs 10天、ICU时间8天 vs 6天、通气时间7天 vs 4天(p<0.001)。
证据类型、等级与局限
- 证据类型:回顾性队列研究(创伤质量改进计划数据库分析)。
- 证据等级:治疗/护理管理;Level III。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于衰弱老年(≥65岁,mFI≥0.25)孤立性钝性胸部创伤且≥2根肋骨骨折患者,SSRF与较低死亡率相关,但未降低呼吸机相关性肺炎、急性呼吸窘迫综合征或气管切开,且与更高的ICU再入率和更长的住院及ICU住院时间相关。
- 作者认为早期SSRF(≤72小时)与减少无计划插管、ICU再入、气管切开、住院时间和通气需求相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Frail geriatric patients with multiple rib fractures face significant morbidity. While surgical stabilization of rib fractures (SSRF) has demonstrated improved outcomes in adults, its efficacy in frail patients remains unclear. We aimed to compare in-hospital outcomes between SSRF and nonoperative management in frail geriatric patients, hypothesizing that SSRF would be associated with lower complications and mortality.
METHODS: A 6-year (2017-2022) retrospective analysis of Trauma Quality Improvement Program database was conducted. Frailty was defined using an 11-factor modified frailty index (mFI) with threshold of ≥0.25. Frail patients ≥65 years with isolated blunt thoracic trauma and ≥2 rib fractures were included. 1:1 propensity score matching adjusted for demographics, injury severity, and baseline characteristics. Primary outcomes were mortality, ventilator-associated pneumonia, acute respiratory distress syndrome, unplanned intubation, intensive care unit (ICU) readmission, and tracheostomy. Secondary outcomes included in-hospital complications, length of stay (LOS), and discharge disposition. PS-matched subanalysis compared early SSRF (≤72 hours) to late SSRF (>72 hours).
RESULTS: Among 53,630 frail rib fracture patients, 2% underwent SSRF. After propensity score matching (1,063 each), SSRF was associated with lower mortality (5.4% vs. 10.2%, p < 0.001) but showed no differences in ventilator-associated pneumonia, acute respiratory distress syndrome, or tracheostomies. Surgical stabilization of rib fracture patients had higher ICU readmission and longer hospital and ICU LOS ( p < 0.05 for all). In the sub-analysis (n = 916), late SSRF was associated with increased unplanned intubation (10.7% vs. 6.8%), ICU readmissions (15.5% vs. 7.6%), tracheostomy (7.0% vs. 3.5%), and longer hospital LOS (13 days vs. 10 days.), ICU LOS (8 days vs. 6 days) and ventilator days (7 days vs. 4 days.) ( p < 0.001 for all).
CONCLUSION: Surgical stabilization of rib fracture is associated with reduced mortality in frail geriatric patients with multiple rib fractures without increasing major complications when compared with nonoperative management. Early SSRF within 72 hours is associated with decreased unplanned intubation, ICU readmission, tracheostomy, LOS, and ventilator requirement in frail patients.
LEVEL OF EVIDENCE: Therapeutic/Care Management; Level III.
参考来源
- Zangbar B, Mehta R, Prabhakaran K, et al. Rib fractures in frail geriatric patients: Does surgical stabilization improve outcomes? J Trauma Acute Care Surg. 2025. PMID: 40828196. doi:10.1097/TA.0000000000004761
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。